Interparfums, Inc. (IPAR)
(Delayed Data from NSDQ)
$121.69 USD
+0.62 (0.51%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $121.49 -0.20 (-0.16%) 7:58 PM ET
1-Strong Buy of 5 1
D Value B Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$121.69 USD
+0.62 (0.51%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $121.49 -0.20 (-0.16%) 7:58 PM ET
1-Strong Buy of 5 1
D Value B Growth D Momentum C VGM
Zacks News
Philip Morris (PM) Q4 Earnings Coming Up: What to Expect?
by Zacks Equity Research
Philip Morris' (PM) fourth-quarter results are likely to reflect strength in smoke-free products and gains from pricing power, though cigarette volumes have been declining year over year.
Estee Lauder (EL) Cuts FY24 Profit View Despite Q2 Earnings Beat
by Zacks Equity Research
Estee Lauder's (EL) second-quarter fiscal 2024 results reflect lower net sales and earnings amid global macroeconomic volatility. Management lowers fiscal 2024 earnings view.
COTY Set to Report Q2 Earnings: Factors to Keep in Mind
by Zacks Equity Research
COTY's second-quarter performance is likely to reflect gains across the Prestige and Consumer Beauty businesses. However, the rising cost of sales is a concern.
Clorox (CLX) Q2 Earnings & Revenues Beat Estimates, Rise Y/Y
by Zacks Equity Research
Clorox (CLX) posts solid second-quarter fiscal 2024 results, backed by higher volumes, and gains from pricing actions and cost-saving initiatives.
Tyson Foods (TSN) Q1 Earnings Coming Up: Is a Beat Likely?
by Zacks Equity Research
Tyson Foods' (TSN) first-quarter results are likely to reflect gains from the company's strategic initiatives and solid brands, though high costs are likely to have played a spoilsport.
Will Inter Parfums (IPAR) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Inter Parfums (IPAR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Things to Note Before Columbia Sportswear's (COLM) Q4 Earnings
by Zacks Equity Research
Columbia Sportswear's (COLM) fourth-quarter results are likely to reflect concerns like soft consumer demand due to a challenging operating landscape.
Altria's (MO) Q4 Earnings Coming Up: Factors Worth Noting
by Zacks Equity Research
Altria's (MO) fourth-quarter results are likely to reflect cigarette volume concerns, though strength in pricing and RRPs is likely to have been an upside.
Colgate (CL) Q4 Earnings & Sales Beat Estimates, '24 View Issued
by Zacks Equity Research
Colgate's (CL) Q4 results benefited from strong sales growth, robust organic volume growth and gross and operating margin expansion.
Inter Parfums (IPAR) Q4 Sales Advance on Brand Strength
by Zacks Equity Research
Inter Parfums' (IPAR) U.S.-based operations witness remarkable 13% sales growth in the fourth quarter, primarily driven by Donna Karan/DKNY.
Inter Parfums (IPAR) Upgraded to Buy: Here's Why
by Zacks Equity Research
Inter Parfums (IPAR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Procter & Gamble (PG) Beats Q2 Earnings Estimates, Ups EPS View
by Zacks Equity Research
Procter & Gamble's (PG) Q2 results reflect robust pricing, along with growth across all segments. All its business segments have seen growth in organic sales.
Inter Parfums' (IPAR) Strategies Poise it for Growth in 2024
by Zacks Equity Research
Buoyed by robust momentum in the fragrance space and gains from product newness, Inter Parfums (IPAR) is set to witness another record year in 2024.
Inter Parfums (IPAR) Benefits From the Booming Fragrance Market
by Zacks Equity Research
Inter Parfums (IPAR) is reaping the benefits of favorable trends in the fragrance market. The company is witnessing increased market share owing to new product launches and brand extensions.
Trends Redefining Beauty: What to Expect in 2024
by Ansuiya Mohta
Inter Parfums (IPAR), COTY, European Wax Center (EWCZ) and Olaplex (OLPX) are well-positioned to continue their growth story in 2024, backed by solid brand images and innovation efforts.
COTY Gains From Solid Beauty Product Business Amid Headwinds
by Zacks Equity Research
COTY gains from strength across its businesses, strategic priorities and cost optimization programs. However, it has been grappling with rising operating costs and expenses.
Here's How Innovation Keeps Colgate (CL) Stock on Growth Track
by Zacks Equity Research
Colgate (CL) has been reaping the benefits of innovation, bold pricing actions, accelerated revenue growth management strategies and efficient execution.
Newell (NWL) Keen on Restructuring & Cost Savings: Stock to Gain
by Zacks Equity Research
Newell (NWL) looks poised for long-term growth on its recently announced restructuring and cost-saving plans. Near-term headwinds related to tough macro conditions and inflation are concerning.
Product Launches Aid Inter Parfums (IPAR), High Costs Ail
by Zacks Equity Research
Inter Parfums (IPAR) is witnessing increased market share owing to new product launches and brand extensions. However, rising SG&A expenses are a concern.
Why Is Inter Parfums (IPAR) Up 2.8% Since Last Earnings Report?
by Zacks Equity Research
Inter Parfums (IPAR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Industry Outlook Highlights Coty, Inter Parfums, e.l.f. Beauty and European Wax Center
by Zacks Equity Research
Coty, Inter Parfums, e.l.f. Beauty and European Wax Center have been highlighted in this Industry Outlook article.
4 Cosmetics Stocks Worth Watching Amid Industry Headwinds
by Ansuiya Mohta
The Zacks Cosmetics industry is facing rising costs and supply-chain-related issues. Focus on digital business and innovations is aiding Coty, e.l.f. Beauty (ELF), Inter Parfums (IPAR) and European Wax Center (EWCZ).
COTY Benefits From its Business Strength, Headwinds Persist
by Zacks Equity Research
COTY benefits from solid momentum in its businesses and cost optimization programs. However, it has been witnessing rising operating costs and expenses.
Inter Parfums (IPAR) Expects Sales & Earnings Growth in 2024
by Zacks Equity Research
Inter Parfums (IPAR) has been gaining from a solid fragrance market and its focus on innovation. It expects net sales and earnings per share to grow year over year in 2024.
Inter Parfums (IPAR) Gains on Solid Brands & Product Launches
by Zacks Equity Research
Inter Parfums (IPAR) appears well-positioned in the booming fragrance market, courtesy of a solid brand portfolio and innovations.